1 – 141 of 141
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
SERPINH1 variants and thrombotic risk among middle-aged and older adults : a population-based cohort study
(
- Contribution to journal › Letter
- 2023
-
Mark
Sex-Specific Risk Factors for Deep Venous Thrombosis and Pulmonary Embolism in a Population-Based Historical Cohort Study of Middle-Aged and Older Individuals
(
- Contribution to journal › Article
-
Mark
Association of Circulating Long Noncoding 7S RNA with Deep Vein Thrombosis
(
- Contribution to journal › Article
-
Mark
Lung function, respiratory symptoms and incident venous thromboembolism during a 44-year follow-up
(
- Contribution to journal › Article
-
Mark
Entrustable professional activities (EPAs) for undergraduate medical education – development and exploration of social validity
(
- Contribution to journal › Article
- 2022
-
Mark
Association between self-rated health and venous thromboembolism in Malmö Preventive Program : A cohort study
(
- Contribution to journal › Article
-
Mark
Classic Thrombophilias and Thrombotic Risk Among Middle-Aged and Older Adults : A Population-Based Cohort Study
(
- Contribution to journal › Article
-
Mark
Thrombotic Risk Determined by Protein C Receptor (PROCR) Variants among Middle-Aged and Older Adults : A Population-Based Cohort Study
(
- Contribution to journal › Article
-
Mark
A prospective, controlled study on the utility of rotational thromboelastometry in surgery for acute type A aortic dissection
(
- Contribution to journal › Article
-
Mark
Genetic variation of the blood coagulation regulator tissue factor pathway inhibitor and venous thromboembolism among middle-aged and older adults: A population-based cohort study
(
- Contribution to journal › Letter
-
Mark
Thrombomodulin (THBD) gene variants and thrombotic risk in a population-based cohort study
(
- Contribution to journal › Article
-
Mark
Thrombotic risk determined by rare and common SERPINA1 variants in a population-based cohort study
(
- Contribution to journal › Article
- 2021
-
Mark
Familial Segregation of Venous Thromboembolism in Sweden: A Nationwide Family Study of Heritability and Complex Segregation Analysis
(
- Contribution to journal › Article
-
Mark
The Association between Blood-Based Global DNA Methylation and Venous Thromboembolism
(
- Contribution to journal › Article
-
Mark
Thrombotic Risk Determined by STAB 2 Variants in a Population-Based Cohort Study
(
- Contribution to journal › Letter
-
Mark
Reactome Pathway Analysis of Venous Thromboembolism, Peripheral Artery Disease, Stroke, and Coronary Artery Disease
(
- Contribution to journal › Letter
-
Mark
Impact of ABO blood group on bleeding complications after surgery for acute type A aortic dissection
(
- Contribution to journal › Article
- 2020
-
Mark
Genetic risk factors for venous thromboembolism
(
- Contribution to journal › Scientific review
- 2019
-
Mark
The Coagulopathy of Acute Type A Aortic Dissection : A Prospective, Observational Study
(
- Contribution to journal › Article
-
Mark
Association of recurrent venous thromboembolism and circulating microRNAs
(
- Contribution to journal › Article
-
Mark
Clinical implications of different risk factor profiles in patients with mesenteric venous thrombosis and systemic venous thromboembolism : a population-based study
2019) In Journal of Thrombosis and Thrombolysis(
- Contribution to journal › Article
-
Mark
Risk prediction of recurrent venous thromboembolism : a multiple genetic risk model
(
- Contribution to journal › Article
-
Mark
The role of von Willebrand factor in acute type A aortic dissection and aortic surgery
(
- Contribution to journal › Article
- 2018
-
Mark
Establishing a regional paediatric registry improved the overview and detection of side effects in children on anticoagulants
(
- Contribution to journal › Article
-
Mark
Evaluation of Expression Level of Apolipoprotein M as a Diagnostic Marker for Primary Venous Thromboembolism
(
- Contribution to journal › Article
-
Mark
Fat mass and obesity-associated gene rs9939609 polymorphism is a potential biomarker of recurrent venous thromboembolism in male but not in female patients
(
- Contribution to journal › Article
-
Mark
Polymorphisms in PARK2 and MRPL37 are associated with higher risk of recurrent venous thromboembolism in a sex-specific manner
(
- Contribution to journal › Article
-
Mark
Identification of novel diagnostic biomarkers for deep venous thrombosis
(
- Contribution to journal › Article
-
Mark
NOAK står säkra i klinisk praxis
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Postoperative Joint Replacement Complications in Swedish Patients With a Family History of Venous Thromboembolism
(
- Contribution to journal › Article
-
Mark
Alpha 2-macroglobulin 5 bp insertion/deletion polymorphism increases the risk of recurrent venous thromboembolism
(
- Contribution to journal › Article
-
Mark
Factor V Leiden paradox in a middle-aged Swedish population : A prospective study
(
- Contribution to journal › Article
- 2017
-
Mark
Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis
(
- Contribution to journal › Article
-
Mark
Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR
(
- Contribution to journal › Article
-
Mark
Venous thromboembolism and cancer risk
(
- Contribution to journal › Article
-
Mark
Safety and Efficacy of Bridging with Low-Molecular-Weight Heparin during Temporary Interruptions of Warfarin : A Register-Based Cohort Study
(
- Contribution to journal › Article
-
Mark
Cohort-specific imputation of gene expression improves prediction of warfarin dose for African Americans
(
- Contribution to journal › Article
-
Mark
Identification of Genetic Aberrations in Thrombomodulin Gene in Patients with Recurrent Venous Thromboembolism
(
- Contribution to journal › Article
-
Mark
Association between TLR9 rs5743836 polymorphism and risk of recurrent venous thromboembolism
(
- Contribution to journal › Article
-
Mark
Ischemic stroke rates decline in patients with atrial fibrillation as anticoagulants uptake improves : A Swedish cohort study
(
- Contribution to journal › Article
-
Mark
Non-Vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin : A retrospective register study
(
- Contribution to journal › Article
- 2016
-
Mark
Antithrombotic therapy in patients with non-valvular atrial fibrillation in Southern Sweden: A population-based cohort study.
(
- Contribution to journal › Article
-
Mark
Thrombomodulin gene c.1418C>T polymorphism and risk of recurrent venous thromboembolism.
(
- Contribution to journal › Article
-
Mark
Bleeding complications in venous thrombosis patients on well-managed warfarin.
(
- Contribution to journal › Article
-
Mark
Epidemiology of Familial Aggregation of Venous Thromboembolism
(
- Contribution to journal › Scientific review
-
Mark
Tydliga råd viktiga när fertila kvinnor förskrivs NOAK
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Incidence and risk factors for thromboembolism and major bleeding in patients with mechanical valve prosthesis : A nationwide population-based study
(
- Contribution to journal › Article
-
Mark
Atrial fibrillation patients with CHA2DS2-VASc > 1 benefit from oral anticoagulation prior to cardioversion
(
- Contribution to journal › Article
-
Mark
Diagnostic potential of plasma microRNA signatures in patients with deep-vein thrombosis
(
- Contribution to journal › Article
-
Mark
Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism
(
- Contribution to journal › Article
-
Mark
Health care resource use and costs of cancer-associated thrombosis in Sweden
(
- Contribution to journal › Article
-
Mark
Ateroskleros och trombogenes
2016) p.21-30(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2015
-
Mark
Studier av antidoter mot NOAK visar goda resultat.
(
- Contribution to journal › Article
-
Mark
Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
(
- Contribution to journal › Article
-
Mark
Safety and efficacy of well managed warfarin: A report from the Swedish quality register Auricula
(
- Contribution to journal › Article
-
Mark
Role of family history of venous thromboembolism (VTE) and thrombophilia as predictors of VTE recurrence: a prospective follow-up study.
(
- Contribution to journal › Article
-
Mark
Factor H Autoantibodies in Patients with Antiphospholipid Syndrome and Thrombosis.
(
- Contribution to journal › Article
-
Mark
Glomerular filtration rate and association to stroke, major bleeding, and death in patients with mechanical heart valve prosthesis.
(
- Contribution to journal › Article
-
Mark
INR variability and outcomes in patients with mechanical heart valve prosthesis.
(
- Contribution to journal › Article
-
Mark
Concomitant use of dronedarone with dabigatran in patients with atrial fibrillation in clinical practice.
(
- Contribution to journal › Article
-
Mark
Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome.
(
- Contribution to journal › Article
-
Mark
Warfarin treatment quality is consistently high in both anticoagulation clinics and primary care setting in Sweden.
(
- Contribution to journal › Article
-
Mark
Warfarin treatment complications do not correlate to cTTR when above 70.
(
- Contribution to journal › Article
-
Mark
Warfarin persistence among stroke patients with atrial fibrillation.
(
- Contribution to journal › Article
-
Mark
Invasive Fusobacterium necrophorum infections and Lemièrre's syndrome: the role of thrombophilia and EBV.
(
- Contribution to journal › Article
-
Mark
Soluble urokinase plasminogen activator receptor and incidence of venous thromboembolism.
(
- Contribution to journal › Article
-
Mark
NOAK i den kliniska vardagen
(
- Contribution to journal › Article
- 2014
-
Mark
Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden.
(
- Contribution to journal › Article
-
Mark
The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease
(
- Contribution to journal › Article
-
Mark
Mechanical heart valve prosthesis and warfarin - Treatment quality and prognosis.
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M and the risk of unprovoked recurrent venous thromboembolism.
(
- Contribution to journal › Article
-
Mark
Transforming growth factor (TGF)-β levels and unprovoked recurrent venous thromboembolism.
(
- Contribution to journal › Article
-
Mark
The association between red cell distribution width and venous thromboembolism: A biochemical evaluation
(
- Contribution to journal › Letter
-
Mark
Thromboembolism, major bleeding and mortality in patients with mechanical heart valves- a population-based cohort study.
(
- Contribution to journal › Article
-
Mark
Desmopressin in treatment of haematological disorders and in prevention of surgical bleeding.
(
- Contribution to journal › Scientific review
-
Mark
Red cell distribution width and risk for venous thromboembolism: A population-based cohort study.
(
- Contribution to journal › Article
-
Mark
Inflammatory plasma markers and risk for venous thromboembolism.
(
- Contribution to journal › Article
-
Mark
Atrial fibrillation patients do not benefit from acetylsalicylic acid
(
- Contribution to journal › Article
- 2013
-
Mark
TEG och ROTEM--patientnära och snabba koagulationsanalyser. Minskar transfusionbehovet vid lever- och hjärtkirurgi, men frågetecken finns.
(
- Contribution to journal › Article
-
Mark
Somatosensory Sensitivity in Patients With Persistent Idiopathic Orofacial Pain Is Associated With Pain Relief From Hypnosis and Relaxation.
(
- Contribution to journal › Article
-
Mark
APC resistance due to Factor V Leiden is not related to baseline inflammatory mediators or survival up to 10 years in patients with critical limb ischemia.
(
- Contribution to journal › Article
-
Mark
Computer aided warfarin dosing in the Swedish national quality registry AuriculA - Algorithmic suggestions are performing better than manually changed doses
(
- Contribution to journal › Article
-
Mark
Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin.
(
- Contribution to journal › Article
-
Mark
Socioeconomic factors and concomitant diseases are related to the risk for venous thromboembolism during long time follow-up.
(
- Contribution to journal › Article
-
Mark
Prasugrel 5-mg in the very elderly attenuates platelet inhibition but maintains non-inferiority to prasugrel 10-mg in non-elderly patients: The GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients.
(
- Contribution to journal › Article
-
Mark
Dabigatran in clinical practice - One-year experience at Skåne University Hospital.
(
- Contribution to journal › Letter
-
Mark
Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation.
(
- Contribution to journal › Article
-
Mark
Treatment with local hemostatic agents and primary closure after tooth extraction in warfarin treated patients.
(
- Contribution to journal › Article
- 2012
-
Mark
Mortality and Inherited Thrombophilia: results from the European Prospective Cohort on Thrombophilia (EPCOT).
(
- Contribution to journal › Article
-
Mark
Computerised assistance for warfarin dosage - Effects on treatment quality
(
- Contribution to journal › Article
-
Mark
Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.
(
- Contribution to journal › Article
-
Mark
Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.
(
- Contribution to journal › Article
-
Mark
Ateroskleros och trombogenes
2012)(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Ateroskleros och trombogenes
2012) p.21-27(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2011
-
Mark
Risk factors for hemorrhage during local intra-arterial thrombolysis for lower limb ischaemia
(
- Contribution to journal › Article
-
Mark
Thrombotic occlusion of all left coronary branches in a young woman with severe ulcerative colitis
2011) In ISRN Cardiology(
- Contribution to journal › Letter
-
Mark
Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA.
(
- Contribution to journal › Article
-
Mark
Glomerular filtration rate in patients with atrial fibrillation on warfarin treatment: A subgroup analysis from the AURICULA registry in Sweden.
(
- Contribution to journal › Article
-
Mark
Ovanliga ärftliga former av blödarsjuka. Blödningssymtom, familjehistoria och laboratorieanalyser ger diagnosen.
(
- Contribution to journal › Article
- 2010
-
Mark
Treatment of Mesenteric Vein Thrombosis
(
- Contribution to journal › Article
-
Mark
The diagnostic performance of APC-PCI complex determination compared to d-dimer in the diagnosis of deep vein thrombosis
(
- Contribution to journal › Article
-
Mark
Upper extremity deep venous thrombosis in the population-based Malmö thrombophilia study (MATS). Epidemiology, risk factors, recurrence risk, and mortality.
(
- Contribution to journal › Article
-
Mark
A Cost-effectiveness Analysis of Diagnostic Algorithms of Deep Vein Thrombosis at the Emergency Department.
(
- Contribution to journal › Article
-
Mark
The effect of low molecular weight heparin (dalteparin) on duration and initiation of labour.
(
- Contribution to journal › Article
-
Mark
Von Willebrands sjukdom--från biokemi till klinisk praxis.
(
- Contribution to journal › Scientific review
- 2009
-
Mark
Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS).
(
- Contribution to journal › Article
-
Mark
Performance of two relatively new quantitative D-dimer assays (Innovance D-dimer and AxSYM D-dimer) for the exclusion of deep vein thrombosis.
(
- Contribution to journal › Article
-
Mark
Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
(
- Contribution to journal › Article
-
Mark
Three-Year Survival and Stroke Recurrence Rates in Patients With Primary Intracerebral Hemorrhage.
(
- Contribution to journal › Article
-
Mark
Trombocytopeni kan vara HIT. Heparinbehandling kan ge livshotande låga trombocytvärden
(
- Contribution to journal › Article
- 2008
-
Mark
Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis
(
- Contribution to journal › Article
-
Mark
The Factor V Leiden mutation is associated with a higher blood haemoglobin concentration in women below 50 of the Malmö Thrombophilia Study (MATS).
(
- Contribution to journal › Article
-
Mark
Epidemiology, risk and prognostic factors in mesenteric venous thrombosis.
(
- Contribution to journal › Article
-
Mark
Blödningstidsbestämning har spelat ut sin roll. Otillförlitlig metod som inte längre bör användas i rutinsjukvården
(
- Contribution to journal › Scientific review
- 2007
-
Mark
Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
(
- Contribution to journal › Article
-
Mark
Menorrhagia and minor bleeding symptoms in women on oral anticoagulation.
(
- Contribution to journal › Article
-
Mark
Evidens för trombosprofylax till medicinpatienter med hög risk
(
- Contribution to journal › Article
- 2006
-
Mark
The complex between activated protein C and protein C inhibitor: A clinically useful indicator of aortic aneurysms?
(
- Contribution to journal › Article
- 2005
-
Mark
Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee.
(
- Contribution to journal › Article
-
Mark
APC-PCI complex concentration is higher in patients with previous venous thromboembolism with Factor V Leiden.
(
- Contribution to journal › Letter
-
Mark
Recurrence Rate After a First Venous Thrombosis in Patients With Familial Thrombophilia.
(
- Contribution to journal › Article
-
Mark
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)
(
- Contribution to journal › Article
- 2004
-
Mark
Familial thrombophilia and lifetime risk of venous thrombosis
(
- Contribution to journal › Article
-
Mark
Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
(
- Contribution to journal › Article
-
Mark
Hereditary thrombophilia and fetal loss: a prospective follow-up study
(
- Contribution to journal › Article
-
Mark
Factor V leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults.
(
- Contribution to journal › Article
- 2003
-
Mark
Risk of haemorrhagic stroke in patients with oral anticoagulation compared with the general population
(
- Contribution to journal › Article
- 2002
-
Mark
Multidisciplinär kurs i akutmedicin ger ST-läkare större säkerhet
(
- Contribution to journal › Article
- 2000
-
Mark
Inflammatory bowel disease promotes venous thrombosis earlier in life
(
- Contribution to journal › Article
- 1999
-
Mark
Nytt system testar den mekaniska hjärtklaffen. Egenkontroll i hemmet av antivitamin K-terapin ger patienten större frihet
(
- Contribution to journal › Article
- 1998
-
Mark
The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families
(
- Contribution to journal › Letter
-
Mark
The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families [3]
(
- Contribution to journal › Letter
- 1997
-
Mark
The factor VR5O6Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis
(
- Contribution to journal › Article
-
Mark
The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis
(
- Contribution to journal › Article
-
Mark
Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls
(
- Contribution to journal › Article
-
Mark
Resistance to activated protein C a novel risk factor for venous thrombosis
1997)(
- Thesis › Doctoral thesis (compilation)
- 1996
-
Mark
Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency
(
- Contribution to journal › Article
- 1995
-
Mark
Resistens mot aktiverat protein C. Vanlig genetisk riskfaktor för venös trombos
(
- Contribution to journal › Article
- 1994
-
Mark
Myocardial infarction associated with homozygous resistance to activated protein C
(
- Contribution to journal › Letter
-
Mark
Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C
(
- Contribution to journal › Article